We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Titan International
TWI
$516M
| $412K | 0.01% |
142,446
+20,268
| +17% | +$44.6K |
|
1577
Zurn Elkay Water Solutions
ZWS
$8.07B
| $412K | 0.01% |
28,649
-18,321
| -39% | -$262K |
|
1578
Artivion
AORT
$1.23B
| $411K | 0.01% |
+22,242
| New | +$425K |
|
1579
Golar LNG
GLNG
$4.95B
| $411K | 0.01% |
+67,879
| New | +$607K |
|
1580
Standard BioTools
LAB
$326M
| $411K | 0.01% |
55,300
-71,127
| -56% | -$491K |
|
|
GWPH
1581
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $411K | 0.01% |
4,225
-3,580
| -46% | -$412K |
|
1582
Zymeworks
ZYME
$1.68B
| $410K | 0.01% |
8,806
-8,456
| -49% | -$290K |
|
1583
Brookfield Renewable
BEPC
$6.12B
| $409K | 0.01% |
+10,475
| New | +$351K |
|
|
EVOP
1584
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $409K | 0.01% |
+16,447
| New | +$413K |
|
1585
Fomento Económico Mexicano
FMX
$43.3B
| $408K | 0.01% |
+7,261
| New | +$424K |
|
1586
RPC Inc
RES
$1.24B
| $408K | 0.01% |
154,728
+88,472
| +134% | +$276K |
|
1587
Barnes & Noble Education
BNED
$412M
| $407K | 0.01% |
1,578
+960
| +155% | +$216K |
|
1588
Itaú Unibanco
ITUB
$91.3B
| $407K | 0.01% |
+140,639
| New | +$478K |
|
|
HAYN
1589
DELISTED
Haynes International, Inc.
HAYN
| $407K | 0.01% |
23,837
+2,821
| +13% | +$57.5K |
|
|
TCDA
1590
DELISTED
Tricida, Inc. Common Stock
TCDA
| $407K | 0.01% |
+44,879
| New | +$655K |
|
|
CFRX
1591
DELISTED
ContraFect Corporation
CFRX
| $407K | 0.01% |
+964
| New | +$437K |
|
1592
Donnelley Financial Solutions
DFIN
$1.21B
| $406K | 0.01% |
30,405
-39,193
| -56% | -$406K |
|
1593
Rogers Corp
ROG
$2.33B
| $403K | 0.01% |
+4,106
| New | +$483K |
|
|
LEAF
1594
DELISTED
Leaf Group Ltd.
LEAF
| $403K | 0.01% |
80,322
+51,242
| +176% | +$242K |
|
|
OXLC
1595
Oxford Lane Capital
OXLC
$830M
| $402K | 0.01% |
18,273
+14,766
| +421% | +$316K |
|
1596
Comscore
SCOR
| $402K | 0.01% |
9,858
+6,070
| +160% | +$337K |
|
1597
Stoneridge
SRI
$209M
| $402K | 0.01% |
21,905
-8,739
| -29% | -$178K |
|
|
MNTV
1598
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $402K | 0.01% |
+18,200
| New | +$423K |
|
1599
CALL
Boston Scientific
BSX
$65.8B
| $401K | 0.01% |
+10,500
| New | +$405K |
|
|
1600
PUT
Boston Scientific
BSX
$65.8B
| $401K | 0.01% |
+10,500
| New | +$405K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.